Park Place Capital Corp Raises Position in Chemed Co. (NYSE:CHE)

Park Place Capital Corp grew its holdings in Chemed Co. (NYSE:CHE) by 33.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,086 shares of the company’s stock after purchasing an additional 522 shares during the quarter. Park Place Capital Corp’s holdings in Chemed were worth $1,105,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Fort Washington Investment Advisors Inc. OH increased its holdings in shares of Chemed by 36.9% during the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 40,898 shares of the company’s stock worth $21,668,000 after buying an additional 11,020 shares during the last quarter. Mitchell & Pahl Private Wealth LLC grew its stake in shares of Chemed by 10.5% in the fourth quarter. Mitchell & Pahl Private Wealth LLC now owns 1,198 shares of the company’s stock worth $635,000 after acquiring an additional 114 shares in the last quarter. Ballentine Partners LLC lifted its position in shares of Chemed by 7.5% during the 4th quarter. Ballentine Partners LLC now owns 704 shares of the company’s stock worth $373,000 after purchasing an additional 49 shares during the last quarter. UMB Bank n.a. lifted its position in shares of Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after purchasing an additional 39 shares during the last quarter. Finally, Smith Salley Wealth Management lifted its position in shares of Chemed by 1.8% during the 4th quarter. Smith Salley Wealth Management now owns 16,988 shares of the company’s stock worth $9,000,000 after purchasing an additional 307 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Chemed

In other news, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now owns 18,287 shares of the company’s stock, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares of the company’s stock, valued at $58,270,755.95. The trade was a 1.93 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is owned by company insiders.

Chemed Stock Up 0.5 %

Shares of Chemed stock opened at $557.49 on Wednesday. The company’s 50-day simple moving average is $545.05 and its 200-day simple moving average is $563.07. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62. The firm has a market cap of $8.39 billion, a price-to-earnings ratio of 28.28, a price-to-earnings-growth ratio of 2.16 and a beta of 0.47.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. During the same quarter in the previous year, the company posted $5.32 earnings per share. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. Equities research analysts anticipate that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were given a dividend of $0.50 per share. The ex-dividend date was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed’s dividend payout ratio (DPR) is currently 10.11%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.